MiR-132 increases proliferation and decreases apoptosis in pancreatic cancer cells by cyclin-D1 downregulation and acting on other important cellular mediators such as caspase-3 or -9 (174). This evidence concerns the gene CCND1 and familial pancreatic carcinoma.